If you are wondering whether ResMed's current share price still offers value, this article walks through what the numbers are ...
ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...
2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem, designed to ...
Zacks Investment Research on MSN
Here's how much a $1000 investment in ResMed made 10 years ago would be worth today
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across ...
ResMed's shares have fallen 37% due to struggles with profitability and investor fears of weight loss drugs, but I believe in its long-term potential. The company reported a 16% increase in revenue ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...
ResMed dominates an enormous, underdiagnosed market with recurring revenue and digital health leadership, yet trades below its historical earnings multiples, offering compelling value. The company’s ...
NEW DELHI--(BUSINESS WIRE)--ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general ...
With the pedal firmly to the metal in its U.S. business—thanks in no small part to rival CPAP machine maker Philips’ ongoing recall—ResMed has begun looking beyond its home turf to extend that winning ...
Connected respiratory device maker ResMed signed a definitive agreement to acquire Medifox Dan, a German out-of-hospital software company, from software investor Hg for $1 billion (€950 million).
San Diego-based medical device company ResMed has announced the acquisition of mementor, a consumer software developer that offers a digital solution for insomnia. The financial terms of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback